Charles Rivera: Unscripted

Structure Therapeutics reports strong Phase 2 data for its oral obesity pill, aleniglipron, positioning it as a key contender in the race for pill-based GLP-1s.

With a new $27M funding round, Sensera Systems is poised to expand its AI-powered jobsite intelligence, transforming construction safety and efficiency.

Fintech giant Chime forecasts its first full year of GAAP profitability in 2026, propelled by its new ChimeCore platform, AI, and strong product growth.

Celebrating its 40th anniversary, the Ricordi® Chamber not only transformed diabetes research but now serves as the foundation for the future of cell therapy.

Leonardo's adoption of the revolutionary Pegasus hoist for its AW139 fleet marks a new era in aviation safety, driven by advanced tech and stricter regulations.

CRC's third 'Grade A' methane certification from MiQ signals a shift toward verifiable, low-emission energy production in California's green transition.

Hanks for Our Troops coffee hits Walmart shelves, channeling 100% of profits to veteran charities. But can celebrity star power brew sustainable change?

Heritage Insurance projects a stunning full-year return on equity over 45%, setting the stage for a blockbuster earnings report on March 9.

Verdiva Bio's VRB-101 aims to be the first once-weekly oral GLP-1, a potential game-changer for patients tired of daily pills and injections.

A new study confirms Theranica's migraine wearable won't disrupt glucose monitors, a major breakthrough for 4.5 million Americans with both conditions.

With over 99% creditor approval, Advantage Solutions restructures its debt, gaining time but facing higher costs and a skeptical stock market.

A 20-year fight to save Nova Scotia salmon from acid rain is now a certified climate technology, attracting major investment and creating a new model for conservation.

New Phase 1b data for oral drug pociredir reveals a robust boost in fetal hemoglobin, as Fulcrum Therapeutics secures a financial runway into 2029.

After 40 years of supplying top chefs, Caputo & Guest now ships its organic Lion's Mane, Shiitake, and Maitake directly from its farm to your door.

Acquiring Complete Genomics, Swiss Rockets unveils its CoolMPS 600, a bid to democratize long-read sequencing with breakthrough cost and accuracy.

Outdoor Holding Co. ends a major legal distraction with a $4.4M payment, allowing it to fully focus on innovating its GunBroker.com marketplace.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.

A2Z Cust2Mate reports a pivotal quarter with up to $5.2M in Q4 revenue, as the delivery of over 2,000 AI-powered smart carts begins to pay off.

A new partnership unveils a program at MWC26 to embed quantum-safe connectivity in IoT devices during manufacturing, aiming to slash costs and complexity.

A massive $97 million deal highlights a consolidation 'gold rush' in outdoor hospitality, reshaping the future of RV travel for campers and investors alike.